BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3489038)

  • 1. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils.
    Khalife J; Capron M; Cesbron JY; Tai PC; Taelman H; Prin L; Capron A
    J Immunol; 1986 Sep; 137(5):1659-64. PubMed ID: 3489038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular release of rat eosinophil peroxidase (EPO) I. Role of anaphylactic immunoglobulins.
    Khalife J; Capron M; Grzych JM; Bazin H; Capron A
    J Immunol; 1985 Mar; 134(3):1968-74. PubMed ID: 3968436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophils: receptors and mediators in hypersensitivity.
    Capron M
    Clin Exp Allergy; 1989 Jan; 19 Suppl 1():3-8. PubMed ID: 2713741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular release of peroxidase from eosinophils by interaction with immune complexes.
    Takenaka T; Okuda M; Kawabori S; Kubo K
    Clin Exp Immunol; 1977 Apr; 28(1):56-60. PubMed ID: 301076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
    Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
    J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes.
    Capron M; Kazatchkine MD; Fischer E; Joseph M; Butterworth AE; Kusnierz JP; Prin L; Papin JP; Capron A
    J Immunol; 1987 Sep; 139(6):2059-65. PubMed ID: 2957447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.
    Moqbel R; Macdonald AJ; Cromwell O; Kay AB
    Immunology; 1990 Mar; 69(3):435-42. PubMed ID: 2312166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation.
    Tomassini M; Tsicopoulos A; Tai PC; Gruart V; Tonnel AB; Prin L; Capron A; Capron M
    J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):365-75. PubMed ID: 1890265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of mediators released by eosinophils.
    Capron M; Tomassini M; Torpier G; Kusnierz JP; MacDonald S; Capron A
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):54-8. PubMed ID: 2523359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and morphologic characterization of eosinophils in the lower intestinal mucosa of patients with food allergy.
    Schwab D; Müller S; Aigner T; Neureiter D; Kirchner T; Hahn EG; Raithel M
    Am J Gastroenterol; 2003 Jul; 98(7):1525-34. PubMed ID: 12873574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotype-specific human suppressor T cells for IgE synthesis activated by IgE-anti-IgE immune complexes.
    Hassner A; Saxon A
    J Immunol; 1984 Jun; 132(6):2844-9. PubMed ID: 6233363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation.
    Lamkhioued B; Gounni AS; Gruart V; Pierce A; Capron A; Capron M
    Eur J Immunol; 1995 Jan; 25(1):117-25. PubMed ID: 7843220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
    Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
    Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IgE receptors in effector function of human eosinophils.
    Capron M; Spiegelberg HL; Prin L; Bennich H; Butterworth AE; Pierce RJ; Ouaissi MA; Capron A
    J Immunol; 1984 Jan; 132(1):462-8. PubMed ID: 6228581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4.
    Munoz NM; Vita AJ; Neeley SP; McAllister K; Spaethe SM; White SR; Leff AR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):139-43. PubMed ID: 8301549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does IgE bind to and activate eosinophils from patients with allergy?
    Kita H; Kaneko M; Bartemes KR; Weiler DA; Schimming AW; Reed CE; Gleich GJ
    J Immunol; 1999 Jun; 162(11):6901-11. PubMed ID: 10352312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ragweed-specific antibodies in bronchoalveolar lavage fluids and serum before and after segmental lung challenge: IgE and IgA associated with eosinophil degranulation.
    Peebles RS; Liu MC; Adkinson NF; Lichtenstein LM; Hamilton RG
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):265-73. PubMed ID: 9500761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-mediated pulmonary eosinophilia in immunoglobulin G1-sensitized guinea pigs: eosinophil peroxidase as a simple specific marker for detecting eosinophils in bronchoalveolar lavage fluid.
    Cheng JB; Pillar JS; Shirley JT; Showell HJ; Watson JW; Cohan VL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):922-9. PubMed ID: 8437132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE-binding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity.
    Truong MJ; Gruart V; Liu FT; Prin L; Capron A; Capron M
    Eur J Immunol; 1993 Dec; 23(12):3230-5. PubMed ID: 8258338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.